Holen Sie sich die Stockscreener-App
25.91
1.41%
0.36
Handel nachbörslich:
25.91
Schlusskurs vom Vortag:
$25.55
Offen:
$25.8
24-Stunden-Volumen:
79,179
Relative Volume:
0.39
Marktkapitalisierung:
$513.46M
Einnahmen:
$71.10M
Nettoeinkommen (Verlust:
$-6.38M
KGV:
-21.58
EPS:
-1.2009
Netto-Cashflow:
$-39.84M
1W Leistung:
+3.39%
1M Leistung:
-3.10%
6M Leistung:
-5.85%
1J Leistung:
+39.68%
1-Tages-Spanne:
$25.80
$26.57
1-Wochen-Bereich:
$24.85
$26.64
52-Wochen-Spanne:
$16.90
$39.70
Assembly Biosciences Inc Stock (ASMB) Company Profile
Firmenname
Assembly Biosciences Inc
Sektor
Branche
Telefon
(833) 409-4583
Adresse
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Compare ASMB vs VRTX, REGN, ARGX, RVMD, ALNY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
25.91 | 506.33M | 71.10M | -6.38M | -39.84M | -1.2009 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-24 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-08-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-03-25 | Eingeleitet | Guggenheim | Buy |
| 2024-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2021-09-13 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-09-02 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | Herabstufung | Jefferies | Buy → Hold |
| 2020-10-19 | Eingeleitet | Truist | Buy |
| 2019-10-16 | Eingeleitet | Mizuho | Buy |
| 2018-11-19 | Eingeleitet | Leerink Partners | Outperform |
| 2018-10-08 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-04-13 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | Eingeleitet | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | Eingeleitet | Jefferies | Buy |
| 2017-05-30 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Assembly Biosciences Inc Aktie (ASMB) Neueste Nachrichten
Assembly Biosciences Inc (ASMB) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Assembly Biosciences Inc (ASMB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Assembly Biosciences Market Sentiment - Benzinga España
Assembly Biosciences Inc (ASMB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Assembly Biosciences Inc (ASMB) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Avoiding Lag: Real-Time Signals in (ASMB) Movement - Stock Traders Daily
Assembly Biosciences Closes Securities Offering - Moomoo
Assembly Biosciences strengthens antiviral plat... - Pluang
Assembly Biosciences: A Gilead-Backed Antiviral Option With More Embedded Leverage Than The Market Appreciates - Seeking Alpha
Assembli to Produce Big Ten Conference Activation at Fanatics Fest in New York - GlobeNewswire Inc.
Enterprise value to EBIT forward of Assembly Biosciences, Inc. – NASDAQ:ASMB - TradingView
Enterprise value to EBIT forward of Assembly Biosciences, Inc. – HAM:V7B - TradingView
Enterprise value to EBIT forward of Assembly Biosciences, Inc. – FWB:V7B - TradingView
Price to earnings forward of Assembly Biosciences, Inc. – FWB:V7B - TradingView
Enterprise value to revenue forward of Assembly Biosciences, Inc. – NASDAQ:ASMB - TradingView
Assembly Biosciences (ASMB) Holds Steady Near Resistance ZoneOverbought Signal Alerts - dars.gov.et
Enterprise value to EBITDA forward of Assembly Biosciences, Inc. – NASDAQ:ASMB - TradingView
Assembly Biosciences Inc: Plans to Initiate a - Moomoo
ASMBAssembly Biosciences Inc Options - Finviz
Discipline and Rules-Based Execution in ASMB Response - Stock Traders Daily
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 2000 Index - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 2000 Value Benchmark - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 3000E Index - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS:ASMB) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 3000 Value Benchmark - marketscreener.com
Assembly Biosciences, Inc.(NasdaqGS: ASMB) added to Russell 3000 Index - marketscreener.com
Health Care had the best week vs. the S&P 500 on record (XLV:NYSEARCA) - Seeking Alpha
Assembly Biosciences, Inc. Actuals & Estimates (NASDAQ:ASMB) - TradingView
Assembly Biosciences, Inc. Actuals & Estimates (TRADEGATE:V7B) - TradingView
ASMB Forecast — Price Target — Prediction for 2027 - TradingView
Assembly Biosciences Inc (ASMB) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Assembly Biosciences Inc (ASMB) Institutional Confidence - TradingKey
Behavioral Patterns of ASMB and Institutional Flows - Stock Traders Daily
Assembly Biosciences (ASMB) PFO sells 29 shares to cover RSU taxes - Stock Titan
Assembly Biosciences Inc (ASMB) Valuation: PE, PB & Fair Value Analysis - TradingKey
Assembly Biosciences Inc (ASMB) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Assembly Biosciences Inc (ASMB) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ASMB Maintained by Mizuho -- Price Target Raised to $45 - GuruFocus
Mizuho Raises Price Target on Assembly Biosciences to $45 From $40, Keeps Outperform Rating - Moomoo
ZVRA Stock Price and Chart — NASDAQ:ZVRA - TradingView
Assembly Biosciences eyes Gilead HSV plan as ABI-6250 liver pipeline expands - MSN
ASMB SEC FilingsAssembly Bioscie 10-K, 10-Q, 8-K Forms - Stock Titan
Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data Ahead - MarketBeat
(ASMB) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Assembly Biosciences Expands Equity Plans, Reelects Board - TipRanks
Assembly Biosciences (ASMB) CMO awarded 14,000-share RSU-based stock grant - Stock Titan
Assembly Biosciences (ASMB) CMO awarded 14,000 restricted stock units - Stock Titan
Assembly Biosciences (NASDAQ: ASMB) awards 8,000 stock options to director McHutchison - Stock Titan
Assembly Biosciences (ASMB) director receives grant of 8,000 stock options - Stock Titan
Director at Assembly Biosciences (ASMB) receives grant of 8,000 stock options - Stock Titan
Finanzdaten der Assembly Biosciences Inc-Aktie (ASMB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):